20/20 Biolabs, Inc.(AIDX)
$0.22+0.03 (+14.87%)
AIDX
20/20 Biolabs, Inc. Revenue
$0.22
At close:+0.03 (+14.87%)
Want to see AIDX full AI Analyst Report?
20/20 Biolabs, Inc. (AIDX) Revenue
14 Followers
20/20 Biolabs, Inc. Revenue
20/20 Biolabs, Inc. had a revenue of 730.57K in the quarter ending Jun 30, 2026, with 106.74%. This bring the company's revenue in the last twelve months to 2.04M, Increased 10.60%. In the fiscal year ending Mar 31, 2026, 20/20 Biolabs, Inc. had annual revenue of 2.05M with 16.71% growth.
- Revenue (ttm)
- 2.04M
- Revenue Growth
- ―
- P/S Ratio
- 1.28
- Revenue/Employee
- $146,081
- Employees
- 14
- Market Cap
- $2.61M
Revenue Chart
20/20 Biolabs, Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.05M | 292.79K | 16.71% |
| Dec 31, 2024 | 1.75M | 328.04K | 23.03% |
| Dec 31, 2023 | 1.42M | -9.63M | -87.12% |
| Dec 31, 2022 | 11.06M | 1.44M | 14.93% |
| Dec 31, 2021 | 9.62M | 7.29M | 312.88% |
| Dec 31, 2020 | 2.33M | 2.04M | 708.37% |
| Dec 31, 2019 | 288.30K | 11.25K | 4.06% |
| Dec 31, 2018 | 277.05K | -36.16K | -11.55% |
| Dec 31, 2017 | 313.21K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.